E Reiszner

596 total citations
16 papers, 509 citations indexed

About

E Reiszner is a scholar working on Infectious Diseases, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, E Reiszner has authored 16 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Pharmacology and 8 papers in Clinical Biochemistry. Recurrent topics in E Reiszner's work include Antimicrobial Resistance in Staphylococcus (13 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Bacterial Identification and Susceptibility Testing (8 papers). E Reiszner is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (13 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Bacterial Identification and Susceptibility Testing (8 papers). E Reiszner collaborates with scholars based in United States. E Reiszner's co-authors include George M. Eliopoulos, R C Moellering, Sandra Willey, Gregory A. Caputo, Peter Spitzer, Christine Wennersten, Robert C. Moellering, Donald A. Goldmann, Jennifer S. Daly and Daniel F. Sahm and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

E Reiszner

16 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Reiszner United States 12 303 205 153 152 126 16 509
B. Hofmann Germany 7 270 0.9× 103 0.5× 101 0.7× 144 0.9× 204 1.6× 9 455
J E Flokowitsch United States 8 308 1.0× 84 0.4× 146 1.0× 95 0.6× 174 1.4× 10 453
Jeffrey R. Aeschlimann United States 14 420 1.4× 214 1.0× 219 1.4× 299 2.0× 235 1.9× 19 750
Elizabeth Gradelski United States 13 135 0.4× 261 1.3× 118 0.8× 260 1.7× 114 0.9× 19 513
M. Husson Belgium 13 175 0.6× 205 1.0× 96 0.6× 176 1.2× 88 0.7× 35 499
B Kolek United States 13 173 0.6× 307 1.5× 89 0.6× 294 1.9× 151 1.2× 16 637
Mary S. Barrett United States 13 167 0.6× 226 1.1× 84 0.5× 163 1.1× 67 0.5× 31 473
C.-J. Soussy France 15 223 0.7× 162 0.8× 102 0.7× 272 1.8× 146 1.2× 29 664
Ronda L. Akins United States 12 385 1.3× 245 1.2× 222 1.5× 160 1.1× 117 0.9× 23 648
Yukio Utsui Japan 11 403 1.3× 311 1.5× 126 0.8× 273 1.8× 334 2.7× 23 815

Countries citing papers authored by E Reiszner

Since Specialization
Citations

This map shows the geographic impact of E Reiszner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Reiszner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Reiszner more than expected).

Fields of papers citing papers by E Reiszner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Reiszner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Reiszner. The network helps show where E Reiszner may publish in the future.

Co-authorship network of co-authors of E Reiszner

This figure shows the co-authorship network connecting the top 25 collaborators of E Reiszner. A scholar is included among the top collaborators of E Reiszner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Reiszner. E Reiszner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hoban, Daryl J., Douglas J. Biedenbach, Daniel F. Sahm, E Reiszner, & Joseph P. Iaconis. (2015). Activity of ceftaroline and comparators against pathogens isolated from skin and soft tissue infections in Latin America – results of AWARE surveillance 2012. The Brazilian Journal of Infectious Diseases. 19(6). 596–603. 12 indexed citations
2.
3.
Biedenbach, Douglas J., Daryl J. Hoban, E Reiszner, et al.. (2015). In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance Program. Antimicrobial Agents and Chemotherapy. 59(12). 7873–7877. 13 indexed citations
4.
Biedenbach, Douglas J., Richard A. Alm, Sushmita D. Lahiri, et al.. (2015). In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program. Antimicrobial Agents and Chemotherapy. 60(1). 343–347. 34 indexed citations
5.
Eliopoulos, George M., E Reiszner, Sandra Willey, W J Novick, & R C Moellering. (1989). Effect of blood product medium supplements on the activity of cefotaxime and other cephalosporins against Enterococcus faecalis. Diagnostic Microbiology and Infectious Disease. 12(2). 149–156. 16 indexed citations
6.
Daly, Jennifer S., George M. Eliopoulos, E Reiszner, & Robert C. Moellering. (1988). Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds. Journal of Antimicrobial Chemotherapy. 21(6). 721–730. 52 indexed citations
7.
Eliopoulos, George M., et al.. (1988). High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrobial Agents and Chemotherapy. 32(10). 1528–1532. 85 indexed citations
8.
Eliopoulos, George M., E Reiszner, Mary Jane Ferraro, & R C Moellering. (1987). Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic. Journal of Antimicrobial Chemotherapy. 20(5). 671–675. 17 indexed citations
9.
Eliopoulos, George M., E Reiszner, & R C Moellering. (1987). In vitro evaluation of the new Paulomycin antibiotic paldimycin. European Journal of Clinical Microbiology & Infectious Diseases. 6(3). 306–308. 2 indexed citations
10.
Eliopoulos, George M., Christine Wennersten, E Reiszner, & R C Moellering. (1987). Comparative in vitro activity of CGP 31608, a new penem antibiotic. Antimicrobial Agents and Chemotherapy. 31(8). 1188–1193. 1 indexed citations
11.
Allan, J. Davis, George M. Eliopoulos, E Reiszner, & Robert C. Moellering. (1987). In vitro activities of ICI 194008 and ICI 193428, two new cephem antimicrobial agents. Antimicrobial Agents and Chemotherapy. 31(12). 1997–2001. 11 indexed citations
12.
Eliopoulos, George M., E Reiszner, Christine Wennersten, & R C Moellering. (1987). In vitro activity of BMY-28100, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy. 31(4). 653–656. 33 indexed citations
13.
Eliopoulos, George M., E Reiszner, Gregory M. Caputo, & R C Moellering. (1986). In vitro activity of CI-934, a new quinolone antimicrobial, against gram-positive bacteria. Diagnostic Microbiology and Infectious Disease. 5(4). 341–344. 3 indexed citations
14.
Eliopoulos, George M., Sandra Willey, E Reiszner, et al.. (1986). In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic. Antimicrobial Agents and Chemotherapy. 30(4). 532–535. 155 indexed citations
15.
Eliopoulos, George M., et al.. (1985). In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620. Antimicrobial Agents and Chemotherapy. 28(4). 514–520. 45 indexed citations
16.
Eliopoulos, George M., E Reiszner, & R C Moellering. (1985). In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria. Antimicrobial Agents and Chemotherapy. 27(1). 28–32. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Hofmann Breakdown of academic impact, for papers by J E Flokowitsch Breakdown of academic impact, for papers by Jeffrey R. Aeschlimann Breakdown of academic impact, for papers by Elizabeth Gradelski Breakdown of academic impact, for papers by M. Husson Breakdown of academic impact, for papers by B Kolek Breakdown of academic impact, for papers by Mary S. Barrett Breakdown of academic impact, for papers by C.-J. Soussy Breakdown of academic impact, for papers by Ronda L. Akins Breakdown of academic impact, for papers by Yukio Utsui
Rankless by CCL
2026